Abivax (ABVX) EV to Revenue (2023 - 2026)

Abivax (ABVX) EV to Revenue (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to Revenue
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	39.46 Mn
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	3,065.60
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	42.37
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	8.62
9	Abivax	94.37 Bn	94.37 Bn	-	17,434.90
10	Regeneron Pharmaceuticals	63.60 Bn	54.85 Bn	3.31 Bn	3.68

Download Data